University Of Vermont

This study looks at whether sending free meals to the home can improve food security for adults receiving medication for opioid use disorder. Forty participants will be split into two groups: one gets nutrition education alone, the other gets education plus weekly meal deliveries…

This study tests whether a common blood thinner (apixaban) can safely prevent dangerous blood clots in cancer patients at moderate risk. About 996 adults with solid tumors or lymphoma will receive either a standard twice-daily dose, a simpler once-daily dose, or no blood thinner …

This study tests a drug called fezolinetant to see if it can reduce hot flashes in men with prostate cancer who are on hormone therapy. Hot flashes are a common side effect that can affect daily life. The drug is already approved for hot flashes in menopausal women. About 32 men …

This study tests whether a newer treatment method called TINLL works better than traditional therapy for people with tennis elbow (lateral elbow pain). About 68 adults will receive either standard care (stretching, taping, TENS) or the TINLL approach (focusing on nerves and layer…

This study tests a short, intensive pulmonary rehabilitation program for people who smoke and have a lung nodule suspicious for cancer. Participants will do breathing exercises and get help quitting smoking before their cancer treatment. The goal is to see if this program is prac…

This study looks at how different types of dietary fats influence brain function in healthy adults aged 65 to 75. Participants will follow two one-week diets—one similar to a typical North American diet and one similar to the Mediterranean diet—while researchers measure memory an…

This study looks at why people with myelodysplastic syndromes (MDS), a type of blood cancer, are more likely to develop heart disease or stroke. Researchers will measure inflammation-related proteins in the blood of 30 adults with MDS over six months. The goal is to find out if t…